Professional Documents
Culture Documents
Monoclonal Antibodies For High-Risk COVID-19 Positive Patients - combatCOVID - Hhs.gov
Monoclonal Antibodies For High-Risk COVID-19 Positive Patients - combatCOVID - Hhs.gov
Español
1 of 9 12/2/21, 10:40 AM
Monoclonal Antibodies for High-Risk COVID-19 Positive Patients | com... https://combatcovid.hhs.gov/i-have-covid-19-now/monoclonal-antibodies...
If you’ve tested positive for COVID-19, one of the first questions you may have is, What can I
do to reduce the risk of getting sicker? The good news is, there are treatments that may
reduce that risk. Depending on your age, health history, and how long you’ve had symptoms
of COVID-19, you may qualify for a promising form of treatment for the disease. It’s called
monoclonal antibody (mAb) treatment.
Some early evidence suggests that mAb treatment can reduce the amount of the SARS-
CoV-2 virus (the virus that causes COVID-19) in a person's system. This amount is known as
viral load. Having a lower viral load means you may have milder symptoms thereby
decreasing the likelihood of you needing to stay in the hospital.
• Have a positive COVID-19 test, and had symptoms for 10 days or less
Visit the page How Do I Know If I’m High Risk, and What Do I Do Next? to learn more.
This page describes what mAbs are, how they can prevent mild to moderate symptoms from
getting worse, and what to expect if you get mAb treatment.
Have symptoms, but no healthcare provider? Call the Combat COVID Monoclonal Antibodies
Call Center at 1-877-332-6585.
FEATURED NEWS
Monoclonal Antibodies in the News
NATIONAL NEWS
The Drug Trial That Could Actually Produce Covid Treatments
2 of 9 12/2/21, 10:40 AM
Monoclonal Antibodies for High-Risk COVID-19 Positive Patients | com... https://combatcovid.hhs.gov/i-have-covid-19-now/monoclonal-antibodies...
Labcorp and the U.S. Department of Health and Human Services Join Forces to Raise
Awareness of COVID-19 Treatments
How the Corporate World, Government Worked Together to Deliver a Solution to the
COVID-19 Pandemic
LOCAL NEWS
Michigan Expands Monoclonal Antibodies Treatment To Cut Hospitalizations, Deaths
'Like Somebody Gave Me A Happy Pill': Monoclonal Antibodies Help Americans Most At
Risk For COVID-19
UPMC Hamot Offering Monoclonal Antibodies For Patients Diagnosed With COVID-19
More news
3 of 9 12/2/21, 10:40 AM
Monoclonal Antibodies for High-Risk COVID-19 Positive Patients | com... https://combatcovid.hhs.gov/i-have-covid-19-now/monoclonal-antibodies...
mAb treatment for COVID-19 is different from a COVID-19 vaccine. A vaccine triggers
your body’s natural immune response, but can take weeks to develop enough antibodies
and prevent some kinds of infection. Some vaccines for COVID-19 require two shots, so
your body can develop its own immune response to the disease. But if you already have
the virus, mAb treatment gives your body the antibodies it needs to protect itself.
4 of 9 12/2/21, 10:40 AM
Monoclonal Antibodies for High-Risk COVID-19 Positive Patients | com... https://combatcovid.hhs.gov/i-have-covid-19-now/monoclonal-antibodies...
People who have had symptoms for 10 days or less should be referred for
treatment by their healthcare providers and directed to available infusion
locations. If you do not have a healthcare provider, call the Combat COVID
Monoclonal Antibodies Call Center at 1-877-332-6585 to find out who to talk with
about your symptoms and treatment.
There is no cost to anyone for the antibodies themselves, but there may be
treatment fees. If you do not have insurance, ask the facility if there will be a
charge.
5 of 9 12/2/21, 10:40 AM
Monoclonal Antibodies for High-Risk COVID-19 Positive Patients | com... https://combatcovid.hhs.gov/i-have-covid-19-now/monoclonal-antibodies...
Whatever the reason is, don’t give up. There could be another option. You may be able to join
a clinical trial for COVID-19.
Participants in these clinical trials may receive new drugs or other treatments, so
researchers can evaluate how well the treatments work. Thousands of participants in clinical
trials have helped with the discovery of new treatments for COVID-19, and many more
participants are needed to make sure that treatments work for people across age, gender,
race, and ethnicity.
Ask your healthcare provider if you may be eligible for a clinical trial for treating COVID-19.
To learn more about clinical trials, visit our page, You Can Help Combat COVID, or call
877-414-8106.
6 of 9 12/2/21, 10:40 AM
Monoclonal Antibodies for High-Risk COVID-19 Positive Patients | com... https://combatcovid.hhs.gov/i-have-covid-19-now/monoclonal-antibodies...
start an IV, which delivers the mAbs to your body in just over an hour. Afterward, the
medical staff will have you stay at the infusion center for another hour to be sure you
aren’t having an allergic reaction or other side effects. These reactions are rare, but the
staff must observe you for this hour. Then you’ll be released to go home.
It’s important to know that even if you start feeling better, you could still spread the
virus for a while. So, you’ll need to isolate yourself (be alone) until all of these things
happen:
2. You haven’t had a fever in at least 24 hours, without taking any medicine
that reduces fever
7 of 9 12/2/21, 10:40 AM
Monoclonal Antibodies for High-Risk COVID-19 Positive Patients | com... https://combatcovid.hhs.gov/i-have-covid-19-now/monoclonal-antibodies...
8 of 9 12/2/21, 10:40 AM
Monoclonal Antibodies for High-Risk COVID-19 Positive Patients | com... https://combatcovid.hhs.gov/i-have-covid-19-now/monoclonal-antibodies...
• Allergic reactions can happen during and after an antibody infusion. Tell
your healthcare provider right away if you get any of the following signs and
symptoms of allergic reactions: fever; chills; nausea; headache; shortness
of breath; low blood pressure; wheezing; swelling of your lips, face, or
throat; rash, including hives; itching; muscle aches; and/or dizziness.
• An infusion of any medicine may cause brief pain, bleeding, bruising of the
skin, soreness, swelling, and possible infection at the infusion site.
These are not all the possible side effects of antibody treatment. Serious and unexpected
side effects may happen. Some possible risks from antibody treatment are:
• It may interfere with your body's ability to fight off a future infection of
SARS-CoV-2.
mAb treatments for COVID-19, like other treatments authorized for emergency use by the
U.S. Food and Drug Administration, are still being studied, so it's possible that we don’t know
all the risks yet. As researchers continue to study the virus and how mAb treatment affects
it, we’ll learn more about these possible risks. If you have any questions, please talk with your
healthcare provider.
9 of 9 12/2/21, 10:40 AM